Loading...
Dapagliflozin for the treatment of type 2 diabetes
INTRODUCTION: Despite the availability of many antihypreglycemic agents, many patients with type 2 diabetes (T2DM) fail to achieve the glycemic treatment goal, primarily due to progressive beta-cell dysfunction, and increased risk of hypoglycemia. AREAS COVERED: The aim of the present article is to...
Na minha lista:
| Udgivet i: | Expert Opin Pharmacother |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5777318/ https://ncbi.nlm.nih.gov/pubmed/23800130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2013.812632 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|